DECEMBER 23, 2020, NEW YORK - Researchers led by Ludwig San Diego Member Don Cleveland and Peter Campbell of the Sanger Center have solved the mystery of how free-floating circular DNA fragments, ...
Company is Developing a Novel Class of Cancer Therapeutics Based on a Biology Platform that Leverages World-Class Scientific Founders’ Pioneering Discoveries about the Role of Extrachromosomal DNA ...
SAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in oncogene amplified cancers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback